BOLT logo

Bolt Biotherapeutics, Inc. (BOLT)

Profile

Full Name

Bolt Biotherapeutics, Inc.

Ticker

NASDAQ: BOLT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 5, 2021

Indexes

Not included

Website

https://www.boltbio.com

Employees

52

Key Details

Price

$4.67(-2.38%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.69M(-2.36% YoY)

Annual EPS

-$33.00(-1703.28% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.67
    BOLT price is $4.67

    30-Day Relative Volume

    0.85
    BOLT 30-day relative volume is 0.85

    Price Performance

    Price Today change

    -2.38%
    BOLT price is down -2.38% today

    Price YTD change

    -56.36%
    BOLT price is down -56.36% since January 1st

    Price 1-year change

    -66.16%
    BOLT price is down -66.16% year-on-year

    Price 3-year change

    -88.09%
    BOLT price is down -88.09% over the past 3 years

    Price Range

    Price All-time high

    $861.40
    BOLT price is currently -99.46% below its historical high of $861.40

    Price 3-year low

    $4.59
    BOLT price is currently +1.74% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.95M
    BOLT market capitalization is $8.95 million

    Market cap 3-year change

    -87.87%
    BOLT market capitalization is down -87.87% over the past 3 years

    Market cap All-time high

    $1.45B
    BOLT market capitalization is currently -99.38% below its historical high of $1.45 billion

    Market cap sector rank

    15.67%
    BOLT market capitalization is higher than 15.67% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.2%
    BOLT shares outstanding is up +0.2% year-on-year

    Shares Outstanding 3-Year Change

    +1.85%
    BOLT shares outstanding is up +1.85% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.90
    BOLT beta is 0.90

    200-day SMA

    $8.46
    BOLT price is currently -44.79% below its 200-day simple moving average

    50-day SMA

    $5.83
    BOLT price is currently -19.90% below its 50-day simple moving average

    RSI

    29.32
    BOLT 14-day relative strength index is 29.32

    Volume

    0.85
    BOLT 30-day relative volume is 0.85

    ATR

    $0.33
    BOLT average true range is $0.33

    10-day Historical Volatility

    42.01%
    BOLT 10-day historical volatility is 42.01%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $7.69M
    BOLT annual revenue is $7.69 million

    Revenue Analysts estimate

    $4.41M
    BOLT annual revenue is currently +74.38% higher than the consensus analysts' forecast

    Revenue 1-year change

    -2.36%
    BOLT annual revenue is down -2.36% year-on-year

    Revenue Sector rank

    45.8%
    BOLT annual revenue is higher than 45.8% of companies in Healthcare sector

    EPS

    EPS

    -$33.00
    BOLT annual earnings per share is -$33.00

    EPS Analysts estimate

    -$16.17
    BOLT annual earnings per share is currently +104.04% higher than the consensus analysts' forecast

    EPS 1-year change

    -1703.28%
    BOLT annual earnings per share is down -1703.28% year-on-year

    EPS Sector rank

    5.31%
    BOLT annual earnings per share is higher than 5.31% of companies in Healthcare sector

    Profit

    Gross profit

    $5.51M
    BOLT annual gross profit is $5.51 million

    Gross margin

    71.64%
    BOLT annual gross profit margin is 71.64%

    Operating profit

    -$68.24M
    BOLT annual operating income is -$68.24 million

    Operating margin

    -887.33%
    BOLT annual operating profit margin is -887.33%

    Net income

    -$63.12M
    BOLT annual net profit is -$63.12 million

    Net margin

    -820.78%
    BOLT annual net profit margin is -820.78%

    Expenses

    Total expenses

    $75.93M
    BOLT annual total expenses is $75.93 million

    Operating expenses

    $75.93M
    BOLT annual total operating expenses is $75.93 million

    Cost of goods sold

    $2.18M
    BOLT annual cost of goods sold is $2.18 million

    Selling, general & administrative expenses

    $18.46M
    BOLT annual SGA is $18.46 million

    Depreciation and amortization

    $1.78M
    BOLT annual depreciation & amortization is $1.78 million

    Interest expense

    $0.00
    BOLT annual interest expense is $0.00

    Income tax

    $0.00
    BOLT annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$68.24M
    BOLT annual earnings before interest & taxes is -$68.24 million

    EBITDA

    -$66.45M
    BOLT annual EBITDA is -$66.45 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $99.63M
    BOLT annual total assets is $99.63 million

    Non current assets

    $48.82M
    BOLT annual long term assets is $48.82 million

    Current assets

    $50.81M
    BOLT annual total current assets is $50.81 million

    Cash and cash equivalents

    $7.21M
    BOLT annual cash & cash equivalents is $7.21 million

    Accounts receivable

    -
    BOLT annual accounts receivable value is unknown

    Inventory

    $0.00
    BOLT annual inventory is $0.00

    Liabilities

    Total liabilities

    $42.43M
    BOLT annual total liabilities is $42.43 million

    Long term liabilities

    $26.58M
    BOLT annual total long term liabilities is $26.58 million

    Current liabilities

    $15.86M
    BOLT annual total current liabilities is $15.86 million

    Accounts payable

    $1.51M
    BOLT annual accounts payable is $1.51 million

    Debt

    Total debt

    $25.21M
    BOLT annual total debt is $25.21 million

    Total debt 1-year change

    +24.68%
    BOLT annual total debt is up +24.68% year-on-year

    Long term debt

    $22.96M
    BOLT annual long term debt is $22.96 million

    Short term debt

    $2.25M
    BOLT annual short term debt is $2.25 million

    Equity & Capital

    Shareholders equity

    $57.20M
    BOLT annual stockholders equity is $57.20 million

    Book value

    $57.20M
    BOLT annual book value is $57.20 million

    Retained earnings

    -$427.40M
    BOLT annual retained earnings is -$427.40 million

    Working capital

    $34.90M
    BOLT annual working capital is $34.90 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$61.29M
    BOLT annual cash flow from operations is -$61.29 million

    Cash from operations 1-year change

    +11.85%
    BOLT annual cash flow from operations is up +11.85% year-on-year

    Cash from investing

    $57.58M
    BOLT annual cash flow from investing activities is $57.58 million

    Cash from investing 1-year change

    -18.95%
    BOLT annual cash flow from investing activities is down -18.95% year-on-year

    Cash from financing

    $108.00K
    BOLT annual cash flow from financing activities is $108.00 thousand

    Cash from financing 1-year change

    -57.31%
    BOLT annual cash flow from financing activities is down -57.31% year-on-year

    CAPEX

    CAPEX

    $41.00K
    BOLT annual capital expenditures is $41.00 thousand

    CAPEX 1-year change

    -80.1%
    BOLT annual capital expenditures is down -80.1% year-on-year

    Free Cash Flow

    Free cash flow

    -$61.33M
    BOLT annual free cash flow is -$61.33 million

    Free cash flow 1-year change

    +12.05%
    BOLT annual free cash flow is up +12.05% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    71.64%
    BOLT annual gross profit margin is 71.64%

    Operating margin

    -887.33%
    BOLT annual operating profit margin is -887.33%

    Net margin

    -820.78%
    BOLT annual net profit margin is -820.78%

    ROA & ROE

    ROA

    -48.66%
    BOLT annual return on assets is -48.66%

    ROE

    -74.28%
    BOLT annual return on equity is -74.28%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BOLT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BOLT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.23
    BOLT price to book ratio is 0.23

    PB ratio Sector rank

    20.57%
    BOLT price to book ratio is higher than 20.57% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.15
    BOLT price to sales ratio is 2.15

    PS ratio Sector rank

    39.63%
    BOLT price to sales ratio is higher than 39.63% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$2.42M
    BOLT enterprise value is -$2.42 million

    Enterprise value Sector rank

    10.21%
    BOLT enterprise value is higher than 10.21% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.05
    BOLT EV/EBITDA is 0.05

    EV/EBITDA Sector rank

    63.41%
    BOLT EV/EBITDA is higher than 63.41% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.20
    BOLT annual current ratio is 3.20

    Quick ratio

    3.20
    BOLT annual quick ratio is 3.20

    Leverage

    Debt to equity

    0.44
    BOLT annual debt to equity ratio is 0.44

    Interest coverage ratio

    -
    BOLT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    1
    BOLT piotroski f-score is 1

    Altman Z-Score

    -7.64
    BOLT altman z-score is -7.64

    Analyst ratings

    Recent major analysts updates

    Aug 15, 25 Lake Street
    Buy
    May 20, 25 Lake Street
    Buy
    May 13, 25 Stifel
    Hold
    Mar 25, 25 Stifel
    Hold
    Mar 25, 25 HC Wainwright & Co.
    Neutral
    Nov 13, 24 HC Wainwright & Co.
    Neutral
    Aug 15, 24 HC Wainwright & Co.
    Neutral
    May 15, 24 Stifel
    Hold
    May 15, 24 Leerink Partners
    Market Perform
    May 15, 24 Jones Trading
    Hold

    Institutional Ownership

    Screeners with BOLT included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Bolt Biotherapeutics, Inc.?
    • Does Bolt Biotherapeutics, Inc. pay dividends?
    • What sector is Bolt Biotherapeutics, Inc. in?
    • What industry is Bolt Biotherapeutics, Inc. in?
    • What country is Bolt Biotherapeutics, Inc. based in?
    • When did Bolt Biotherapeutics, Inc. go public?
    • Is Bolt Biotherapeutics, Inc. in the S&P 500?
    • Is Bolt Biotherapeutics, Inc. in the NASDAQ 100?
    • Is Bolt Biotherapeutics, Inc. in the Dow Jones?
    • When was Bolt Biotherapeutics, Inc.'s last earnings report?
    • When does Bolt Biotherapeutics, Inc. report earnings?

    What is the ticker symbol for Bolt Biotherapeutics, Inc.?

    The ticker symbol for Bolt Biotherapeutics, Inc. is NASDAQ:BOLT

    Does Bolt Biotherapeutics, Inc. pay dividends?

    No, Bolt Biotherapeutics, Inc. does not pay dividends

    What sector is Bolt Biotherapeutics, Inc. in?

    Bolt Biotherapeutics, Inc. is in the Healthcare sector

    What industry is Bolt Biotherapeutics, Inc. in?

    Bolt Biotherapeutics, Inc. is in the Biotechnology industry

    What country is Bolt Biotherapeutics, Inc. based in?

    Bolt Biotherapeutics, Inc. is headquartered in United States

    When did Bolt Biotherapeutics, Inc. go public?

    Bolt Biotherapeutics, Inc.'s initial public offering (IPO) was on February 5, 2021

    Is Bolt Biotherapeutics, Inc. in the S&P 500?

    No, Bolt Biotherapeutics, Inc. is not included in the S&P 500 index

    Is Bolt Biotherapeutics, Inc. in the NASDAQ 100?

    No, Bolt Biotherapeutics, Inc. is not included in the NASDAQ 100 index

    Is Bolt Biotherapeutics, Inc. in the Dow Jones?

    No, Bolt Biotherapeutics, Inc. is not included in the Dow Jones index

    When was Bolt Biotherapeutics, Inc.'s last earnings report?

    Bolt Biotherapeutics, Inc.'s most recent earnings report was on August 14, 2025

    When does Bolt Biotherapeutics, Inc. report earnings?

    The date for Bolt Biotherapeutics, Inc.'s next earnings report has not been announced yet
    On this page